↓ Skip to main content

Cochrane Database of Systematic Reviews

Radiofrequency ablation in the treatment of liver metastases from colorectal cancer

Overview of attention for article published in Cochrane database of systematic reviews, June 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 tweeter
facebook
1 Facebook page

Citations

dimensions_citation
122 Dimensions

Readers on

mendeley
165 Mendeley
Title
Radiofrequency ablation in the treatment of liver metastases from colorectal cancer
Published in
Cochrane database of systematic reviews, June 2012
DOI 10.1002/14651858.cd006317.pub3
Pubmed ID
Authors

Roberto Cirocchi, Stefano Trastulli, Carlo Boselli, Alessandro Montedori, Davide Cavaliere, Amilcare Parisi, Giuseppe Noya, Iosief Abraha

Abstract

Colorectal cancer (CRC) is the most common malignant tumour and the third leading cause of cancer deaths in USA. For advanced CRC, the liver is the first site of metastatic disease; approximately 50 % of patients with CRC will develop liver metastases either synchronously or metachronously within 2 years after primary diagnosis. Hepatic resection (HR) is the only curative option, but only 15-20% of patients with liver metastases from CRC (CRLMs) are suitable for surgical standard treatment. In patients with unresectable CRLMs downsizing chemotherapy can improve resectability (16%). Modern systemic chemotherapy represents the only significant treatment for unresectable CRLMs. However several loco-regional treatments have been developed: hepatic arterial infusion (HAI), cryosurgical ablation (CSA), radiofrequency ablation (RFA), microwave ablation and selective internal radion treatment (SIRT). During the past decade RFA has superseded other ablative therapies, due to its low morbidity, mortality, safety and patient acceptability.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 165 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 <1%
Lebanon 1 <1%
Unknown 163 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 21 13%
Student > Master 20 12%
Student > Ph. D. Student 19 12%
Researcher 17 10%
Student > Postgraduate 12 7%
Other 40 24%
Unknown 36 22%
Readers by discipline Count As %
Medicine and Dentistry 81 49%
Nursing and Health Professions 11 7%
Psychology 6 4%
Biochemistry, Genetics and Molecular Biology 4 2%
Business, Management and Accounting 3 2%
Other 15 9%
Unknown 45 27%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 February 2021.
All research outputs
#13,114,750
of 20,378,425 outputs
Outputs from Cochrane database of systematic reviews
#10,313
of 12,047 outputs
Outputs of similar age
#66,710
of 110,854 outputs
Outputs of similar age from Cochrane database of systematic reviews
#83
of 102 outputs
Altmetric has tracked 20,378,425 research outputs across all sources so far. This one is in the 33rd percentile – i.e., 33% of other outputs scored the same or lower than it.
So far Altmetric has tracked 12,047 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.1. This one is in the 13th percentile – i.e., 13% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 110,854 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 102 others from the same source and published within six weeks on either side of this one. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.